Transparency Market Research in its new report titled, “Plasmapheresis Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 – 2026,” provides key insights on the plasmapheresis market. The TMR report anticipates that the increase in health care expenditure coupled with rise in global per capita income will drive the plasmapheresis market during the forecast period i.e, 2018-2026. Moreover, improving health care infrastructure and government reimbursement programs in the developed as well as developing countries are expected to drive the global plasmapheresis market during the forecast period, says the report. Moreover, quality and advancements have been the success drivers of the plasmapheresis industry in order to increase the quality of life of patients and to guarantee donor safety.
Plasma acquired via apheresis technology or complete blood donation processing can either be assembled or fractionated into plasma protein products that comprise one or more purified plasma protein or transfused directly to patients, as per the report.
The TMR report has segregated the global plasmapheresis market based on indication, product type, application, technology, end-user, and region. On the basis of indication, the global plasmapheresis market is segregated into neurological disorders, renal disorders, autoimmune disorders, metabolic disorders, and hematological disorders.
The neurological disorders segment can be divided into Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis, multiple sclerosis, and neuromylitis optica. The renal disorders segment can be classified into anti-gbm disease (Goodpasture’s syndrome), Wagner’s granulomatosis (anca-associated rapidly progressive glomerulonephritis), and post renal transplant rejection. The hematological disorders segment can be segmented into thrombotic thrombocytopenic purpura, cryoglobulinemia, multiple myeloma, Waldenstrom microglobulinemia, and hemolytic uremic syndrome.
In terms of product, the market is bifurcated into devices and disposables (filters, tubing, etc.). On the basis of application, the plasmapheresis market is classified into therapeutic plasmapheresis and source plasma collection. The source plasma segment can be categorized into source plasma and recovered plasma.
In terms of technology, the global plasmapheresis market is divided into membrane filtration and centrifugation. On the basis of end-user, the market is segmented into biopharmaceutical industry, hospitals & specialty clinics, and others (blood collection centers, therapeutic plasma collection centers, blood banks, etc.). On a geographical stand, the global plasmapheresis market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
North America dominated the global plasmapheresis market in 2017 owing to increase in awareness among doctors. Moreover, plasmapheresis is gradually being accepted in the treatment of rare diseases such as Goodpasture’s syndrome, thrombotic thrombocytopenic purpura (TTP), Guillain-Barré syndrome, and Wegener’s Granulomatosis.
Some of the key companies in the global plasmapheresis market are profiled in this report to give a better competitive analysis and these include Asahi Kasei Corporation, Grifols, S.A., Octapharma AG, Kedrion Biopharma (KED Plasma), B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Haemonetics Corporation, and Terumo Corporation.
Request a free brochure report here – http://bit.ly/2HriNS6
About Us
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
